Company Summary
Flagship Labs 97 Inc. (FL97) is a privately held, early-stage technology company pioneering the application of artificial intelligence to transform every aspect of the scientific method. FL97 is backed by Flagship Pioneering, which brings the courage, long-term vision, and resources needed to realize unreasonable results. Join our mission-driven team and contribute to the future of science.
Our Physical Sciences effort is developing a novel AI and data-driven approach to materials discovery and development to accelerate the transition to a sustainable economy.
At FL97, we are uniquely cross-functional and collaborative. We are actively reimagining the way teams work together and communicate. Therefore, we seek individuals with an inclusive mindset and a diversity of thought. Our teams thrive in unstructured and creative environments. All voices are heard because we know that experience comes in many forms, skills are transferable, and passion goes a long way.
If this sounds like an environment you’d love to work in, even if you only have some of the experience listed below, please apply.
Responsibilities
- Design and implement thermochemical assays for a suite of sustainability-focused chemical transformations
- Work with the Automation/Engineering team to design thermochemical reactors and integrate them with analytical methods to evaluate material performance
- Design and implement accelerated stress testing for quantifying stability of both the catalyst and the reaction rate
- Design and implement experiments that reveal optimal reaction conditions and feedstock requirements, including tolerance to impurities
- Collaborate with Experimental team to test synthesized materials
- Collaborate with the Computational team to implement data processing, data interpretation, and quality control algorithms into thermocatalysis workflows
- Develop hypotheses and experiment-computation workflows, leveraging thethe custom thermochemical assays you develop
- Actively manage the execution of science campaigns based on the designed workflows
- Work with the Computation team to develop AI decision-making agents that accelerate hypothesis testing and exploration of catalyst, reaction conditions, etc.
- Work with the Science team to design integrations of thermocatalytic transformations into multi-step chemical processes
- Contribute to the design of scientific campaigns
- Analyze, report, and present findings of experiments to the FL97 research team
Qualifications
- Hands-on and direct experience working with thermocatalysis and reactor engineering
- Experience with design and implementation of a breadth of thermochemical reactors, spanning packed-bed and batch reactors
- Experience with coupling reactors to analytical tools such as Fourier-transform infrared spectroscopy (FTIR) and gas chromatography (GC)
- Experience with thermochemical systems engineering
- Experience with co-design of catalysts and reactions
- Experience with automation of thermochemical experiments
- PhD in Chemical Engineering, Chemistry, Materials Science, or related field
- Strong self-starter and independent thinker, with strong attention to detail
- Excellent communication and presentation skills, capable of conveying technical information in a clear and thorough manner
- Eager to work with highly skilled and dynamic teams in a fast-paced, entrepreneurial, and technical setting
Preferred Qualifications
- Experience synthesizing and characterizing multiple material types
- Experience with thermochemical separations
- Experience with workflow automation
- Experience with multiphysics modelling of thermochemical systems
More About Flagship Pioneering
Flagship Pioneering is a platform innovation company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. Many of the companies Flagship has founded have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture. Flagship has been recognized twice on FORTUNE’s “Change the World” list, an annual ranking of companies that have made a positive social and environmental impact through activities that are part of their core business strategies, and has been twice named to Fast Company’s annual list of the World’s Most Innovative Companies. Learn more about Flagship at www.flagshippioneering.com.
Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.
Recruitment & Staffing Agencies: Flagship Pioneering and its affiliated Flagship Lab companies (collectively, “FSP”) do not accept unsolicited resumes from any source other than candidates. The submission of unsolicited resumes by recruitment or staffing agencies to FSP or its employees is strictly prohibited unless contacted directly by Flagship Pioneering’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of FSP, and FSP will not owe any referral or other fees with respect thereto.
Top Skills
What We Do
Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability.
Since its launch in 2000, the firm has applied a unique, hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $30 billion in aggregate value. To date, Flagship is backed by >$3 billion of aggregate capital commitments, of which over $1.5 billion has been deployed toward the founding and growth of its pioneering companies alongside >$10 billion of follow-on investments from other institutions.
The current Flagship ecosystem includes Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Moderna Therapeutics (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).